Mpac Share Discussion Threads

[bigbigdave] 08/9/2022 06:09

At least FREYR get a mention this time.

Financial Highlights

· Order intake of £32.8m (2021: £51.7m) contributing to a closing order book of £62.6m (30 June 2021: £62.0m; 31 Dec 2021: £78.4m)

· Group revenue of £50.6m up 14% (2021: £44.2m), with Original Equipment up 17% and Service revenue up 6%

· Underlying* profit before tax of £1.1m (2021: £4.7m)

· Underlying* earnings per share of 3.6p (2021: 18.3p)

· Statutory loss before tax of £0.4m (2021: £2.8m profit)

· Basic loss per share of (3.6)p (2021: earnings 10.6p)

· Cash of £9.5m (30 June 2021: £11.2m; 31 Dec 2021: £14.5m)

Positive discussions with FREYR Battery (''FREYR'') towards agreeing a framework agreement for the exclusive supply of battery cell automation lines

[castleford tiger] 01/8/2022 21:46

This was the remaking shares I bought to trade at 225
Happy coming out over 300 with this batch.
My holding remains the same.

[shaker44] 01/8/2022 11:47

You closed our already Tiger?? You know something that makes you nervous?

[castleford tiger] 01/8/2022 09:46

Out of my trading position now.

[castleford tiger] 25/7/2022 15:12

Shaker44 I hold a very large stake before the last batch

[shaker44] 22/7/2022 20:19

Surprised Tiger. I expect this to outperform as the market recovers,even though that will take time.
But I have been wrong before!

[castleford tiger] 22/7/2022 15:48

Sold half of the 55000 between 260/5

[clanger66] 15/7/2022 15:18

Huge volume printed at 250p

[castleford tiger] 12/7/2022 09:47

55000 at 2.25 order being filled about halfway there

[my retirement fund] 12/7/2022 09:46

If its a struggle to do 13p eps this year the risk money is going to be off the table next year so £1.50 may break as the economy tanks in the coming months ahead.

[fuji99] 12/7/2022 09:20

IMO I cannot see any reason for the share price not to return to sub 150p as nothing would give it a stimulus to recover in 2022. This is valid for all stocks as retail sales is falling as never before and many other factors in addition to Russia/Ukraine - are pointing to economic hardship or even a recession.
Some bad news around. - - -

[shaker44] 12/7/2022 03:17

In these markets what looks cheap today maybe cheaper next month. Waiting it out feels like the best strategy.

[apatel21] 11/7/2022 18:35

Tiger you'll bounce backReally tricky markets and even trickier economic backdrop - massive drop off in demand in May/June seems to be catching a lot of Co's outYour invested in good quality Co's with strong Balance Sheets - must make them susceptible to a takeover

[richjp] 11/7/2022 17:03

This is one I luckily got right as I sold out completely at around 600P in August September last year. Unfortunately I am still holding other shares where in retrospect I wish I had also sold.

I was concerned all along that they were likely to encounter supply chain issues, as so much of their new client work seems to be involved in custom solutions involving products from multiple suppliers.

I still think they are a well managed company and in a couple of years the share price will be back at its previous heights however I am not bold enough to go in now.

I will watch and wait and possibly buy in when the recovery is well established even if I have to pay a bit more.

[disc0dave45] 11/7/2022 10:48

Extract from this mornings small cap value report on Stockopedia:"But the company's broker previously had an adj. EPS forecast of 34.5p. It has today reduced that forecast to 13.7p, or by 60%.The forecast for next year is reduced by 26%, to 27.4p."

[my retirement fund] 11/7/2022 10:31

If that forecast is true it looks grossly overpriced even after this mornings haircut

[disc0dave45] 11/7/2022 10:16

Their broker has apparently reduced this FY eps by 60% to 13.7p, and by 26% for next year to 27.4p (according to commentary on Stockopedia).Had previously had this on my watchlist but their pension contributions (circa £2.3m pa to 2025) put me off. It will now virtually match their profits for this FY, that's a big chunk to be paying. I'm also concerned with the messages the BoD are putting out, they virtually implied in May that the majority of costs were being mitigated, well a 60% reduction in bottom line earnings suggests to me that they clearly were not on top of resolving their supply chain issues and subsequent costs.As the Dr posted, feel for holders and let's hope they do sort the issues out for 2023 - it's then looking decent value!.

[scepticalinvestor] 11/7/2022 09:41

Still abt 50% over valued - will wait for the low 1s for a dead cat bounce

[dr biotech] 11/7/2022 08:23

Looks a bit overdone, but bear markets magnify losses and I’m not expecting any sort of bounce anytime soon.

This has been on my watchlist for a while as it makes up part of scsw model portfolio (which has suffered heavily recently). I’ve taken plenty of hits recently so feel for those in here. Presumably a recession will help ease supply lines and transport costs for thos that survive it.

[tiswas] 11/7/2022 07:47

Sorry to hear that CT. You could do no wrong 18 months ago but it seems to have gone pearshaped with quite a few you hold recently.

The stretch options package agreed and notified a week or so ago persuaded me to tip my toe back in the water here. Big mistake. Clearly you cannot read between the lines on any rns these days!

[castleford tiger] 11/7/2022 07:36

Ouch holding far to many

[fuji99] 11/7/2022 07:18

It has issued only 20 million shares; so the swings upwards or downwards are always wild. This will now stagnate for the remainder of 2022 without adding the global effects such as inflation, possible recession and the ongoing Russia/Ukraine conflict without any end on sight. IMO I cannot see any sector where to invest anymore in 2022 except large pharmas such as AZN/GSK and to some extent HIK. I am out for the remainder of the year and will remain so if no visibility in world economy is flagged up. I have nothing to lose by being out but a lot if I remain in such a swinging - on a daily basis - uncertain market.

[mngf] 11/7/2022 07:16

The issue is that they expect things to get better next year, which they may not....